Thursday, April 30, 2026
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
  • My Account
  • Log In
Daily Remedy
  • Home
  • Articles
  • Podcasts
    How NADAC, WAC, and ASP Shape Drug Costs

    How NADAC, WAC, and ASP Shape Drug Costs

    April 20, 2026
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
  • Surveys

    Surveys

    Public Perception of Peptide Regulation and Compounding Practices

    Public Perception of Peptide Regulation and Compounding Practices

    April 19, 2026
    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    How NADAC, WAC, and ASP Shape Drug Costs

    How NADAC, WAC, and ASP Shape Drug Costs

    April 20, 2026
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
  • Surveys

    Surveys

    Public Perception of Peptide Regulation and Compounding Practices

    Public Perception of Peptide Regulation and Compounding Practices

    April 19, 2026
    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Uncertainty & Complexity

Bonds That Tie Diseases

Medicine has always been an experience

Daily Remedy by Daily Remedy
May 6, 2023
in Uncertainty & Complexity
0
The Bonds That Tie Diseases

Unsplash

Funny how some rare diseases garner massive media attention while others languish in silence. We often focus on the differences among these diseases, noting the demographics of the patients afflicted or the most apparent, differentiating symptom. In reality, there’s more that binds diseases together than sets them apart.

Nineteenth century Parisian physician, Jean Martin Charcot said it best: “Disease is very old, and nothing about it has changed. It is we who change, as we learn to recognize what was formerly imperceptible.” This increasing cognizance, seeing what was previously unknown, connects all diseases to one another. Patients would describe it as the experience of living with the disease; the shame in presenting symptoms to a physician only to be disregarded; the humiliation in feeling a certain way only to be told those feelings aren’t real.

Shame and humiliation are fundamental to the human condition. Children feel it when they’re scolded. Adults feel it when they endure professional or personal setbacks. It’s never pleasant. But it’s one of the few things we all share.

It’s through this shared experience that patients of different rare, complex diseases must come together. When we adjust our perception of one disease, to better recognize the symptoms and its effects on patients, we should then extend that progression to other diseases of similar complexity.

Patients with Long COVID or post-COVID syndrome were initially dismissed or told their symptoms would quickly resolve when those symptoms first appeared during the pandemic. Months went by, but they still persisted. With it came the anguish of shame and humiliation, exacerbating an already unpredictable disease. Years later, we’re developing consensus models to understand common presenting symptoms and to derive diagnostic criteria. Finally, these patients have been heard.

This only happened because the patients afflicted advocated for their condition to be properly recognized – all while enduring its symptoms. They changed the perception of their disease and subsequently, now receive the care they deserve. As a sign of their success, we’re seeing research dollars pour into the study of Long COVID and post-COVID syndrome.

Other similarly amorphous, complex rare diseases are not so lucky. Take patients with chronic, intractable pain. Most suffer through years of misdiagnoses, one after another, while navigating the byzantine world of disability claims before they receive the care and support they need. Some don’t make it.

Patient suicide, once a taboo topic, is now more openly discussed. It’s one of the many perception shifts slowly materializing for chronic pain patients. But more progress is needed.

Chronic pain patients can achieve this by connecting with patient advocacy organizations that support other diseases. Start by identifying similarities in the conditions. There are quite a few. Reporter Ryan Prior, himself a patient struggling with Chronic Fatigue Syndrome, noted similarities in his condition with those who had Long COVID. Once he got diagnosed with COVID, he experienced the similarities firsthand.

Experience, more than anything else, matters most to patients. Chronic pain patients should be mindful of that when reaching out to other organizations. It’s the common bond that ties all diseases.

After all, if federal agencies like the CDC and NIH can invest research dollars into studying the early symptoms of traumatic brain injury in combat veterans, then they can also study the fluctuating symptoms of chronic pain. Both diseases affect patients in similar ways. Both begin with an initial disbelief of the patient, create lingering shame and humiliation, and progress through an array of missteps and misdiagnoses before landing on the actual diagnosis.

When patients with different rare diseases meet, they discuss their experiences, often starting with the most painful ones. That’s what really matters: a patient and his or her perception of disease. Regardless of how technologically advanced medicine gets, it will forever remain beholden to patient experiences. Until we improve upon those experiences, we’ll limit the quality of care we provide.

Fortunately, we know how to fix this. We just have to implement what we already know. As Dr. William Osler said, “Listen to the patient; he [or she] is telling you the diagnosis.”

ShareTweet
Daily Remedy

Daily Remedy

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

summary

An in-depth exploration of drug pricing, including key databases like NADAC, WAC, and ASP, and how they influence the pharmaceutical supply chain, policy, and patient advocacy. The episode also introduces MedPricer's innovative pricing intelligence platform, offering valuable insights for healthcare professionals, policymakers, and patients.

Chapters

00:00 Understanding Drug Pricing Dynamics
03:52 Exploring the Drug Pricing Database
10:07 Patient Advocacy and Drug Pricing
13:56 Market Intelligence in Drug Pricing
How NADAC, WAC, and ASP Shape Drug CostsDaily Remedy
YouTube Video X-Tfwy7XKEg
Subscribe

Policy Shift in Peptide Regulation

Clinical Reads

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

by Daily Remedy
April 19, 2026
0

Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...

Read more

Join Our Newsletter!

Twitter Updates

Tweets by TheDailyRemedy

Popular

  • Employer-Sponsored Insurance Is Breaking Down. Price Data Tells You Where It’s Happening First.

    Employer-Sponsored Insurance Is Breaking Down. Price Data Tells You Where It’s Happening First.

    0 shares
    Share 0 Tweet 0
  • Chronic Care Toolbox

    1 shares
    Share 0 Tweet 0
  • Drug Pricing Transparency in an Era of Political Polarization: What MedPricer’s Data Reveals About a Contested Policy Landscape

    0 shares
    Share 0 Tweet 0
  • State Regulators and the Federal Data Gap: How MedPricer Fills What CMS Leaves Incomplete

    0 shares
    Share 0 Tweet 0
  • The Importance of Access Control in the Workplace

    0 shares
    Share 0 Tweet 0
  • 628 Followers

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Join Our Newsletter!

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2026 Daily Remedy

No Result
View All Result
  • Home
  • Articles
  • Podcasts
  • Surveys
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner

© 2026 Daily Remedy